Patent · US Expired

Compounds and therapeutic methods

US6632822B1 · kind B1 · utility

37Cited by
2References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 27, 2002
Grant dateOct 14, 2003
Priority date
Expiry dateFeb 27, 2022

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to indolo[3,2-j]phenanthridine compounds and their use in the treatment of cancer and other diseases of humans and animals including parasitic diseases such as those of Apicomplexan origin, compositions containing said compounds and methods of treatment using them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.